Literature DB >> 23969006

EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib--Letter.

Pei Jye Voon1, Dana Wai Yi Tsui, Nitzan Rosenfeld, Tan Min Chin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23969006     DOI： 10.1158/1535-7163.MCT-13-0192

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN： 1535-7163            Impact factor:   6.261


× No keyword cloud information.
  18 in total

Review 1.  Targeting Acquired and Intrinsic Resistance Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer.

Authors:  Manan P Shah; Joel W Neal
Journal:  Drugs       Date:  2022-04-12       Impact factor: 9.546

Review 2.  EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment.

Authors:  Alex Friedlaender; Vivek Subbiah; Alessandro Russo; Giuseppe Luigi Banna; Umberto Malapelle; Christian Rolfo; Alfredo Addeo
Journal:  Nat Rev Clin Oncol       Date:  2021-09-24       Impact factor: 66.675

Review 3.  Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy.

Authors:  Yoshihisa Kobayashi; Tetsuya Mitsudomi
Journal:  Cancer Sci       Date:  2016-08-09       Impact factor: 6.716

Review 4.  Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer.

Authors:  Simon Vyse; Paul H Huang
Journal:  Signal Transduct Target Ther       Date:  2019-03-08

5.  Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing.

Authors:  Eunhyang Park; Hyo Sup Shim
Journal:  Cancer Res Treat       Date:  2019-11-08       Impact factor: 4.679

Review 6.  Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer.

Authors:  Peter T Harrison; Simon Vyse; Paul H Huang
Journal:  Semin Cancer Biol       Date:  2019-09-25       Impact factor: 15.707

7.  Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger Sequencing.

Authors:  Chaoyue Liang; Zhuolin Wu; Xiaohong Gan; Yuanbin Liu; You You; Chenxian Liu; Chengzhi Zhou; Ying Liang; Haiyun Mo; Allen M Chen; Jiexia Zhang
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

8.  Variability of EGFR exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors.

Authors:  YanRu Qin; Hong Jian; Xiaoling Tong; Xue Wu; Fufeng Wang; Yang W Shao; Xinmin Zhao
Journal:  Mol Oncol       Date:  2020-06-15       Impact factor: 6.603

Review 9.  Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors.

Authors:  Justin A Chen; Jonathan W Riess
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

10.  [Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer].

Authors:  Wensheng Zhou; Wei Zhang; Baohui Han
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.